Providers MS Center

Our Providers

Learn more about our team of leading specialists brings together expertise across neurology, neuro-ophthalmology, neuropsychology, and rehabilitation medicine.

Conditions We Treat

  • Multiple sclerosis
  • Clinically isolated syndrome
  • Radiologically Isolated Syndrome
  • Neuromyelitis optica
  • Optic neuritis
  • Transverse myelitis
  • Acute Disseminated Encephalomyelitis
  • Autoimmune Encephalitis
  • CNS Vasculitis

Infusion Therapy

The Weill Cornell Medicine MS Center features a dedicated infusion room staffed by a specialized team of infusion nurses with expertise in the most advanced MS therapies. Thoughtfully designed to make treatment as comfortable and stress-free as possible, patients relax in ergonomic recliners in a serene, private environment while receiving personalized IV disease-modifying treatments. 


About the Multiple Sclerosis Center

The Weill Cornell Medicine Multiple Sclerosis Center is dedicated to improving the lives of people living with MS through comprehensive, personalized care. We bring together leading clinicians and researchers to improve outcomes today while advancing treatments for tomorrow.

Our mission is to:

  • Provide multidisciplinary care that addresses the medical, cognitive, emotional, and rehabilitative needs of patients and families.
  • Limit disability and restore function through innovative diagnostics, therapies, and clinical trials.
  • Advance clinical, translational, and basic research to identify new multiple sclerosis treatments and regenerative strategies.
  • Translate discovery into real-world impact through collaboration across neurology, imaging, immunology, and genetics.

group photo

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021

Phone: (646) 962-9800
Fax: (646) 962-0390



What We Offer


Personalized, Multidisciplinary Care

Our neurologists develop individualized treatment plans using advanced diagnostic tools and the most current therapies. Care may include disease-modifying treatments, symptom management, and coordinated rehabilitation services tailored to each patient’s needs.

Nurses provide education and ongoing support related to medications, symptom management, and daily living with MS. Clinical social workers offer individualized guidance and help patients and families navigate emotional, cognitive, and practical challenges associated with the disease.

Infusion Therapy

The Weill Cornell Medicine MS Center features a dedicated infusion room staffed by a specialized team of infusion nurses with expertise in the most advanced MS therapies.

Research and Clinical Trials

Research is a core mission of the MS Center. Our clinical, translational, and basic science programs focus on limiting disability, restoring function, and advancing new treatments for multiple sclerosis. Patients may have opportunities to participate in clinical trials evaluating novel therapies designed to slow disease progression and promote repair.

Our research spans neuroscience, immunology, genetics, and advanced imaging, including efforts to better visualize axons and myelin and to develop regenerative strategies for MS.

Specialty Services

Patients benefit from coordinated care with specialists in neuro-ophthalmologyrehabilitative medicineurologyneuropsychologyneuroradiology, and neurosurgery. Physical and cognitive rehabilitation services are integrated into care to support function, independence, and quality of life.



Events

Apr 08

Neurology Grand Rounds

Apr 08 to 9:30am
Lecture Topic: "Cancer Immunotherapy and Neurological Toxicities" Sarah Wesley, MD, MPH Assistant Professor of Neurology Columbia University...

Mar 27

Breathe, Stretch, Visualize: Yoga Session

Mar 27 to 1:00pm
Breathe, Stretch, Visualize: Yoga Session Presented by Kristin Law Yoga Instructor Schedule: 11:00 AM - 12:00 PM | Yoga Session 12:00 PM...


Our ProvidersOur ProvidersOur ProvidersOur Providers
Featured articles


New

New study addresses the safety of intravenous methylprednisolone (IVMP) during breastfeeding.

It is well known that the risk of an MS flair increases dramatically in the post-partum period.  As a consequence, women with MS who have recently given birth are faced with the difficult question of should they continue breast feeding while taking steroids (methylprednisolone is a glucocorticoid, a type of steroid) or should they stop breast feeding.  There has been little scientific guidance on this subject in the past leaving women in the difficult position of deciding on their own as to the...
Potential

Potential new medication for progressive MS shows promise in early trial

While the treatment armamentarium for MS has vastly expanded in the last decade and continues to grow, these treatments have been predominantly for the relapsing forms of the disease, and effective treatments for progressive MS remain a glaring need.Ibudilast (MN-166, MediciNova) is a phosphodiesterase inhibitor with anti-inflammatory properties and potentially neuroprotective activity as well, which was tested in a Phase 2 trial of progressive MS patients.Ibudilast has been marketed in Japan...